Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy.
作者信息
Salama Guy
机构信息
Department of Medicine University of Pittsburgh, School of Medicine Pittsburgh PA.
出版信息
J Am Heart Assoc. 2022 Aug 2;11(15):e026634. doi: 10.1161/JAHA.122.026634. Epub 2022 Jul 19.
Abstract
摘要
相似文献
1
Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy.血管紧张素II受体阻滞剂与心室肥厚中的心律失常
J Am Heart Assoc. 2022 Aug 2;11(15):e026634. doi: 10.1161/JAHA.122.026634. Epub 2022 Jul 19.
2
Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor.
Cardiology. 2003;99(2):61-7. doi: 10.1159/000069722.
3
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
J Cardiovasc Pharmacol. 2002 Apr;39(4):610-9. doi: 10.1097/00005344-200204000-00017.
4
Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization.人类1型血管紧张素II受体在心脏中的特异性过表达会导致复极化延迟。
Cardiovasc Res. 2008 Apr 1;78(1):53-62. doi: 10.1093/cvr/cvn020. Epub 2008 Jan 31.
5
Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy.血管紧张素 II 型 1a 受体信号直接导致心脏肥厚中的心律失常性增加。
Br J Pharmacol. 2013 Dec;170(7):1384-95. doi: 10.1111/bph.12328.
6
Non-antiarrhythmic drugs for the prevention of cardiac arrhythmias.
Ital Heart J. 2005 Mar;6(3):175-9.
7
Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.厄贝沙坦与卡托普利对易患心力衰竭的雄性SHHF/Mcc-fa(cp)大鼠心脏肥大及基因表达影响的比较
J Cardiovasc Pharmacol. 1999 Mar;33(3):451-60. doi: 10.1097/00005344-199903000-00016.
8
Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.血管紧张素受体阻滞剂在心律失常防治中的作用。
Am J Cardiol. 2006 Mar 15;97(6):921-5. doi: 10.1016/j.amjcard.2005.10.028. Epub 2006 Feb 3.
9
Role of the renin-angiotensin system in cardiac hypertrophy.肾素-血管紧张素系统在心肌肥厚中的作用。
Am J Cardiol. 1999 Jun 17;83(12A):53H-57H. doi: 10.1016/s0002-9149(99)00259-3.
10
Small-conductance Ca-activated K channel activation deteriorates hypoxic ventricular arrhythmias via CaMKII in cardiac hypertrophy.小电导钙激活钾通道的激活通过心肌肥厚中的 CaMKII 恶化低氧性室性心律失常。
Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H262-H272. doi: 10.1152/ajpheart.00636.2017. Epub 2018 Apr 6.
引用本文的文献
1
Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province.心脑血管疾病患者联合用药安全性：基于湖北省药品不良反应自发报告数据库的分析
Front Pharmacol. 2025 Jan 8;15:1451713. doi: 10.3389/fphar.2024.1451713. eCollection 2024.
本文引用的文献
1
Candesartan Cilexetil Attenuates Arrhythmogenicity Following Pressure Overload in Rats via the Modulation of Cardiac Electrical and Structural Remodeling and Calcium Handling Dysfunction.坎地沙坦西酯通过调节心脏电重构和结构重构以及钙处理功能障碍减轻大鼠压力超负荷后的心律失常性。
J Am Heart Assoc. 2022 Aug 2;11(15):e024285. doi: 10.1161/JAHA.121.024285. Epub 2022 Jul 19.
2
Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction.沙库巴曲缬沙坦与血管紧张素抑制剂及射血分数降低的心力衰竭患者心律失常终点事件的关系
Heart Rhythm O2. 2021 Dec 17;2(6Part B):724-732. doi: 10.1016/j.hroo.2021.09.009. eCollection 2021 Dec.
3
Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients.沙库巴曲缬沙坦对慢性心力衰竭患者室性心律失常长期发生率的影响。
J Clin Med. 2019 Oct 2;8(10):1582. doi: 10.3390/jcm8101582.
4
The place of ARBs in heart failure therapy: is aldosterone suppression the key?血管紧张素受体阻滞剂在心力衰竭治疗中的地位：醛固酮抑制是关键吗？
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719868134. doi: 10.1177/1753944719868134.
5
Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?沙库巴曲缬沙坦也是一种抗心律失常药物吗？
Circulation. 2018 Aug 7;138(6):551-553. doi: 10.1161/CIRCULATIONAHA.118.034755.
6
Prolonged ATR activation induces Ca1.2 channel internalization in rat cardiomyocytes.ATR 的持续激活可导致大鼠心肌细胞中的 Ca1.2 通道内化。
Sci Rep. 2017 Aug 31;7(1):10131. doi: 10.1038/s41598-017-10474-z.
7
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF).沙库巴曲缬沙坦在射血分数降低的心力衰竭患者中的早期应用：来自“遵循指南-心力衰竭（GWTG-HF）”的见解。
JACC Heart Fail. 2017 Apr;5(4):305-309. doi: 10.1016/j.jchf.2016.12.018.
8
AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function.血管紧张素 II 型受体：在心血管和肾功能中的有益代偿调节作用。
Pflugers Arch. 2013 Jan;465(1):99-110. doi: 10.1007/s00424-012-1146-3. Epub 2012 Sep 5.
9
Angiotensin receptor blockers for heart failure.用于治疗心力衰竭的血管紧张素受体阻滞剂
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD003040. doi: 10.1002/14651858.CD003040.pub2.
10
Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction.缬沙坦对心肌梗死后大鼠程控电刺激诱导的室性心律失常的影响。
J Cell Mol Med. 2012 Jun;16(6):1342-51. doi: 10.1111/j.1582-4934.2011.01502.x.
Zotero 插件